Linaclotide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Linaclotide and local guidelines before prescribing.
Secretagogue
Mechanism
Guanylate cyclase-C agonist.
Uses
Constipation-predominant IBS.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, abdominal pain, flatulence.
Interactions
Few.
Contraindications and cautions
GI obstruction
Monitoring
Bowel function
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Take 30 minutes before food; review at 4 weeks.
More from the textbook: uses, cautions and other points
- Laxatives for IBS with constipation (avoid lactulose - causes bloating); linaclotide if others fail.
Gastroenterology: Anatomy Physiology Pharmacology - Constipation: Soluble fibre (ispaghula), macrogol (avoid lactulose - causes bloating); linaclotide if laxatives have failed after 12 months.
Gastroenterology: Bowel Disorders - Prokinetic / secretagogue | Prucalopride (5-HT4 agonist), linaclotide | Increase colonic movement or fluid secretion | Chronic constipation and IBS with constipation not helped by other laxatives (specialist or after 6–12 months)
Gastroenterology: Anatomy Physiology Pharmacology - If at least 2 laxatives have failed for 6 months: Prucalopride (a prokinetic) or linaclotide.
Gastroenterology: Bowel Disorders - Linaclotide | IBS-C when laxatives have failed; diarrhoea is common.
Gastroenterology: Bowel Disorders
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Bowel Disorders (3 mentions)